InsidersTradesSigma
제테마 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 제테마 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 제테마 has published 121 reports. Market capitalisation: €155bn. The latest transaction was filed on 3 July 2026 (Purchase). Among the most active insiders: 박종우. Every trade is openly available.
121
Insider Decl.
n/a
Thresholds
€277,791
27 ops.
Buy Volume
€4m
15 ops.
Sell Volume
23Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,549 of 28,065 companies
24.5
score / 100
Value23
Quality27
FCF yld-2.9%
Earn yld-4.1%
EV/EBITDA24.5x
ROE-8.2%
Gross mgn48%
Net mgn-8.6%
Debt/EBITDA10.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 3 July 2026
Declarations121 total
25 of 121 declarations
About 제테마
제테마 is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It specializes in the development and commercialization of pharmaceutical products.